Oesophageal cancer is a clinically challenging disease that requires a multidisciplinary
approach. Extensive treatment might be associated with a considerable decline in health …

Gastrointestinal (GI) cancer is a prevailing global health disease with a high incidence rate
which varies by region. It is a huge economic burden on health care providers. GI cancer …

Esophageal cancer is a male-dominant aggressive malignancy and a leading cause of
cancer-related mortality worldwide. Squamous cell carcinoma and adenocarcinoma are the …

Background For endoscopic resection of early GI neoplasia, endoscopic submucosal
dissection (ESD) achieves higher rates of complete resection (R0) than endoscopic mucosal …

Background and Aims Focal EMR followed by radiofrequency ablation (f-EMR+ RFA) and
stepwise or complete EMR (s-EMR) are established strategies for eradication of Barrett's …

Gastrointestinal cancers are a leading cause of mortality, accounting for 23% of cancer‐
related deaths worldwide. In order to improve outcomes from these cancers, novel tissue …

Barrett oesophagus (BE), the only known histological precursor of oesophageal
adenocarcinoma (EAC), is a condition in which the squamous epithelium of the oesophagus …

Background and Aims A prior randomized study (Surveillance versus Radiofrequency
Ablation study [SURF study]) demonstrated that radiofrequency ablation (RFA) of Barrett's …

Background & Aims Barrett's esophagus (BE) recurs in 25% or more of patients treated
successfully with radiofrequency ablation (RFA), so surveillance endoscopy is …

Background and Aims Long-term durability data for effectiveness of radiofrequency ablation
(RFA) to prevent esophageal adenocarcinoma in patients with dysplastic Barrett's …